Abstract
Dialysis encephalopathy is a progressive neurological disease which usually causes death in six to eight months. Although primarily occurring in hemodialyzed uremic patients, it is being seen with increasing frequency in non-dialyzed uremic patients and patients on peritoneal dialysis. Based on strong biochemical and epidemiological data, aluminum has been implicated in the pathogenesis of this disease. Although the source of the aluminum loading was initially felt to be from aluminum-contaminated dialysate, it has more recently become apparent that aluminum loading can occur from the orally administered, aluminum-containing, phosphate-binding gels. In view of the known toxicity of aluminum, the minimum amount of aluminum-containing, phosphate-binding gels should be administered to control serum phosphorus levels, and alternate methods of phosphate control should be sought.
Highlights
A severe, often fatal encephalopathy which has been attributed to accumulation in the brain of aluminum from dialysate prepared with inadequately purified water
Summary
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
